|
|
histone methylation
|
GO:0016571 |
71 |
0.521
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.511
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.510
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.458
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.430
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.403
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.384
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.332
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.321
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.316
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.313
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.310
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.299
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.262
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.228
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.222
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.155
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.154
|
Human |
|
|
gene silencing
|
GO:0016458 |
38 |
0.149
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.143
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.140
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.140
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.134
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.133
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.133
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.132
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.127
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.126
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.124
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.121
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.116
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.116
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.116
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.112
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.112
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.112
|
|
|
|
response to inactivity
|
GO:0014854 |
4 |
0.106
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.105
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.098
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.093
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.091
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.090
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.086
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.085
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.081
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.081
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.081
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.079
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.079
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.077
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.071
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.071
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.068
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.068
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.067
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.066
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.065
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.065
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.064
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.062
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.062
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.061
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.060
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.060
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.060
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.060
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.059
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.058
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.058
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.058
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.058
|
|
|
|
positive regulation of histone methylation
|
GO:0031062 |
16 |
0.057
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.057
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.056
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.055
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.055
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.054
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.054
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.054
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.054
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.053
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.053
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.053
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.053
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.052
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.051
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.051
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.051
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.050
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.049
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.049
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.049
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.049
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.048
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.048
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.048
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.048
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.048
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.047
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.046
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.046
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.045
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.045
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.045
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.045
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.045
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.044
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.044
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.043
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.043
|
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.043
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.042
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.042
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.042
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.041
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.040
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.040
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.040
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.040
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.040
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.040
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.040
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.040
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.039
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.039
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.039
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.039
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.039
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.038
|
|
|
|
cerebral cortex radial glia guided migration
|
GO:0021801 |
17 |
0.038
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.038
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.038
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.038
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.038
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.038
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.038
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.038
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.037
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.037
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.037
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.037
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.037
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.037
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.036
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.036
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.036
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.036
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.035
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.035
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.035
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.035
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.035
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.035
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.035
|
|
|
|
cerebral cortex radially oriented cell migration
|
GO:0021799 |
31 |
0.034
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.034
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.034
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.034
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.034
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.034
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.033
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.033
|
Human |
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.033
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.033
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.033
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.032
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.032
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.031
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.031
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.031
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.031
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.031
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.031
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.030
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.029
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.029
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.029
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.029
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.029
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.029
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.029
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.029
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.029
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.028
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.028
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.028
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.028
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.028
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.028
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.028
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.028
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.028
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.028
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.028
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.028
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.028
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.028
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.028
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.028
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.028
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.027
|
|
|
|
mesenchymal cell proliferation involved in ureter development
|
GO:0072198 |
4 |
0.027
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.027
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.027
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.027
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.027
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.026
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.026
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.026
|
|
|
|
response to muscle inactivity involved in regulation of muscle adaptation
|
GO:0014877 |
4 |
0.026
|
|
|
|
central nervous system segmentation
|
GO:0035283 |
3 |
0.026
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.026
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.026
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.026
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.026
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.026
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.026
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.025
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.025
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.025
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.025
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.025
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.025
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.025
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.025
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.025
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.025
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.025
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.025
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.025
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.024
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.024
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.024
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.024
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.024
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.024
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.024
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.024
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.024
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.024
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.024
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.024
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.024
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.024
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.023
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.023
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.023
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.023
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.023
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.023
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.023
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.022
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.022
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.022
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.022
|
|
|
|
chromatin mediated maintenance of transcription
|
GO:0048096 |
2 |
0.022
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.022
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.022
|
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
16 |
0.022
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.022
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.022
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.022
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.022
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.021
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.021
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.021
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.021
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.021
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.021
|
|
|
|
regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000583 |
2 |
0.021
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.021
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.021
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.021
|
|
|
|
smad protein signal transduction
|
GO:0060395 |
21 |
0.021
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.020
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.020
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.020
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.020
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.020
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.020
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.020
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.020
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.020
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.020
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.020
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.020
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.020
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.020
|
|
|
|
negative regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000584 |
2 |
0.020
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.020
|
|
|
|
regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010640 |
9 |
0.020
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.019
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.019
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.019
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.019
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.019
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.019
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.019
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.019
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.019
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.019
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.019
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.019
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.019
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.019
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.019
|
|
|
|
segment specification
|
GO:0007379 |
15 |
0.019
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.019
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.019
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.019
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.019
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.019
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.018
|
|
|
|
extraocular skeletal muscle development
|
GO:0002074 |
2 |
0.018
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.018
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.018
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.018
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.018
|
|
|
|
regulation of skeletal muscle fiber differentiation
|
GO:1902809 |
3 |
0.018
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.018
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.018
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.018
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.018
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.018
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.018
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.018
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.018
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.018
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.018
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.018
|
|
|
|
glandular epithelial cell maturation
|
GO:0002071 |
2 |
0.017
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.017
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.017
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.017
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.017
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.017
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.017
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.017
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.017
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.017
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.017
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.017
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.017
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.017
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.017
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.017
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.017
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.017
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.017
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.017
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.016
|
|
|
|
epithelial cell maturation involved in prostate gland development
|
GO:0060743 |
4 |
0.016
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.016
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.016
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.016
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.016
|
|
|
|
response to muscle inactivity
|
GO:0014870 |
4 |
0.016
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.016
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.016
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.016
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.016
|
|
|
|
specification of organ position
|
GO:0010159 |
3 |
0.016
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.016
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.016
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.016
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.016
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.016
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.016
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.016
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.016
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.016
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.016
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.016
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.016
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.016
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.016
|
|
|
|
regulation of mesenchymal cell proliferation involved in lung development
|
GO:2000790 |
2 |
0.016
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.016
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.016
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.015
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.015
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.015
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.015
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.015
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.015
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.015
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.015
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.015
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.015
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.015
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.015
|
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.015
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.015
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.015
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.015
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.015
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.015
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.015
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.015
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.014
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.014
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.014
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.014
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.014
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.014
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.014
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.014
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.014
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.014
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.014
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.014
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.014
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.014
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.014
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.014
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.014
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.014
|
|
|
|
regulation of tongue muscle cell differentiation
|
GO:2001035 |
2 |
0.014
|
|
|
|
epithelial cell maturation
|
GO:0002070 |
15 |
0.014
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.014
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.014
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.014
|
|
|
|
vagus nerve morphogenesis
|
GO:0021644 |
2 |
0.014
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.014
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.014
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.014
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.014
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.014
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.014
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.014
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.014
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.014
|
|
|
|
carbon catabolite regulation of transcription
|
GO:0045990 |
4 |
0.014
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.014
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
4 |
0.013
|
|
|
|
cerebellar cortex morphogenesis
|
GO:0021696 |
32 |
0.013
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.013
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.013
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.013
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.013
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.013
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.013
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.013
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.013
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.013
|
|
|
|
visceral motor neuron differentiation
|
GO:0021524 |
3 |
0.013
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.013
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.013
|
|
|
|
response to denervation involved in regulation of muscle adaptation
|
GO:0014894 |
4 |
0.013
|
|
|
|
mammary placode formation
|
GO:0060596 |
4 |
0.013
|
|
|
|
rhombomere 5 development
|
GO:0021571 |
4 |
0.013
|
|
|
|
negative regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010642 |
7 |
0.013
|
|
|
|
cellular response to estrogen stimulus
|
GO:0071391 |
12 |
0.013
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.013
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.013
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.013
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.013
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.013
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.013
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.013
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.013
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.013
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.013
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.013
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.013
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.013
|
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.013
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.013
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.013
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.013
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.013
|
|
|
|
rab protein signal transduction
|
GO:0032482 |
1 |
0.013
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.013
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
3 |
0.013
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.013
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.012
|
|
|
|
smad protein complex assembly
|
GO:0007183 |
1 |
0.012
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.012
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.012
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.012
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.012
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.012
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.012
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.012
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.012
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.012
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.012
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.012
|
|
|
|
positive regulation of skeletal muscle fiber differentiation
|
GO:1902811 |
2 |
0.012
|
|
|
|
positive regulation of mrna metabolic process
|
GO:1903313 |
17 |
0.012
|
|
